Additional Content
THIRD BRIDGE IN THE NEWS
CNBC: Affirm beats on top and bottom lines
THIRD BRIDGE IN THE NEWS
The Standard: Asos delivers another huge loss but insists it can see ‘green shoots’ at last
THIRD BRIDGE IN THE NEWS
Reuters: Stellantis revenues slide as automaker cuts bloated inventories
THIRD BRIDGE IN THE NEWS
BNN Bloomberg: Eli Lily’s Q3 falls shorts as weight-loss drug sales disappoint
THIRD BRIDGE IN THE NEWS
Reuters: Caterpillar forecast hit by lower N. America stockpiling, weak Europe, Asia/Pacific
THIRD BRIDGE IN THE NEWS
Fierce Pharma: Eli Lilly’s tirzepatide products come up more than $1B short of expectations in Q3
THIRD BRIDGE IN THE NEWS
The Times: Are investors in X having second thoughts about Elon Musk?
THIRD BRIDGE IN THE NEWS